Black Diamond Therapeutics (BDTX) Return on Assets (2020 - 2026)
Black Diamond Therapeutics' (BDTX) quarterly Return on Assets came in at 0.0% in Q1 2026, little changed YoY from 0.0% in Q1 2025, and down 855.94% on a QoQ basis from 0.0% in Q4 2025.
Black Diamond Therapeutics (BDTX) Return on Assets (2020 - 2026) Analysis & Trends
Black Diamond Therapeutics (BDTX) has 7 years of Return on Assets data on file, last reported at 0.0% in Q1 2026.
- Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.01%, up 1.0% from the prior year.
- Return on Assets eased to 0.0% in Q1 2026, from 0.0% in the prior quarter.
- In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q2 2023.
- A 5-year average of 0.01% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it gained 1 bps.
- Tracing BDTX's Return on Assets over 5 years: stood at 0.01% in 2022, then grew by 3 bps to 0.01% in 2023, then retreated by 12 bps to 0.01% in 2024, then soared by 106 bps to 0.0% in 2025, then tumbled by 856 bps to 0.0% in 2026.
- The last three Return on Assets figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.57 Bn | 130.72 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.99 Bn | 77.99 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 65.00 Bn | 59.82 Bn | 1.37 Bn | - |
| 4 | Moderna | 56.27 Bn | 51.13 Bn | 52.00 Mn | 0.00% |
| 5 | BeOne Medicines | 42.00 Bn | 36.90 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 27.68 Bn | 9.29 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.43 Bn | 26.27 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.34 Bn | 26.51 Bn | - | 0.00% |
| 10 | Black Diamond Therapeutics | 125.35 Mn | 14.84 Mn | - | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -0.01% |
| Sep 30, 2024 | -0.01% |
| Jun 30, 2024 | -0.01% |
| Mar 31, 2024 | -0.01% |
| Dec 31, 2023 | -0.01% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.01% |
| Dec 31, 2021 | -0.01% |
| Sep 30, 2021 | -0.01% |